In HR+ advanced breast cancer
Learn more about the relevance of PIK3CA Mutations in aBC
Watch the Video now
PIK3CA mutations are found in ~40% of HR+ breast cancer patients and associated with a poor prognosis1-3,5
Alpha isoform selectivity may play a role in the future
This is a global website and is intended for healthcare professionals. The information on this site is intended for educational purposes only and is not country-specific.